Insights
Research and perspectives on the data, AI and standards reshaping life sciences.
Article6 min read9 Sep 2026
AI implementation in pharma: a thought-provoking series
Why most AI pilots in pharma stall, what an agent needs to work reliably, what to ask before investing, and where the FDA and EMA are heading.
Julieta Villafañe
Article8 min read22 Jul 2026
From Documents to Data: The Prerequisite Behind Pharma's AI Implementation
The FDA and EMA are moving the industry away from documents and writing the rulebook around AI use, on 2026-2028 deadlines.
Julieta Villafañe
Questions and comments
Correspondence on these articles is welcome.
Get in touch